Dear Colleagues,

Women's Cancer Initiative - Tata Memorial Hospital and Nag Foundation would like to invite you for the "9th Edition of Year in Review: Breast Cancer Conference". This conference will be held on Fri 12^th January 2024 at CJ Hall, ITC Grand Central, Parel, Mumbai & Sat 13^th, Sun 14^th January 2024 at Prof. R.D. Choksi Auditorium, Tata Memorial Hospital, Mumbai. This meeting will be held in-person.

YIR BC has been one of the most successful annual conferences which I am sure you must have witnessed. YIR BC has over 150 faculty + around 250 registration. For YIR BC we also support travel grants for 70 students.

The idea of this conference is to recapitulate the best breast cancer science every year in a Year in Review format. The theme of the meeting is ‘Breast Cancer: The Year That Was…2023’. With this meeting we aim to capture the best original scientific abstracts and deliberations covered in the major oncology conferences that took place in the preceding year. In this major conference we aim to cover surgical, radiation, medical, pathology, biomarkers, imaging related abstracts making this meeting truly multidisciplinary.

The meeting will be broadly classiﬁed in the following sessions:

Loco-regional therapy
Estrogen Receptor Positive disease
HER2 positive disease
Triple Negative Breast Cancer
Translational Science
State-of-the-Science talk(s)
Rapid Review Session

Please find below the registration link for the conference. We request you to popularise this link amongst your colleagues and students.

www.riverroute.in/yearinreview2024

YIR has become an important annual meeting in India for breast cancer. We have been going strong since 2016 with your support and partnership. We urge you to be part of YIR this year as well.

We look forward to your participation in 2024.

With best wishes,

Organizing Chairperson:

Dr. Sudeep Gupta
Director, Tata Memorial Centre
Professor of Medical Oncology,
Tata Memorial Hospital,
Mumbai

Dr. Shona Nag
Director of Oncology,
Sahyadri Group of Hospitals,
Pune

Scientific Program 2024

Coming Soon

Dr. Hope Rugo, USA

Clinical Professor, Department of Medicine (Hematology/Oncology);
and Director, Breast Oncology Clinical Trials Program, UCSF
San Francisco, CA

Dr. Hope Rugo is a medical oncologist and hematologist specializing in breast cancer research and treatment. A Clinical Professor of Medicine, Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at UCSF in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer. She entered the field of breast cancer in order to incorporate novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer.

Dr. Rugo is the Director of the Breast Oncology Clinical Trials Program, and is the principalinvestigator of multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late stage breast cancer. In addition, Dr. Rugo is working on studies to evaluate cognitive function in women receiving chemotherapy for breast cancer, as well as novel ways to reduce toxicity from therapy. Dr. Rugo has established collaborations with a number of other large academic medical centers for the purpose of expanding the novel therapies that are available for our patients, including herbal agents that appear to have an antitumor effect in the laboratory. She is an active member of the national cooperative group, CALGB, and she is a founding member of the Breast Cancer Research Consortium, as well as serving as an investigator in the UCSF Breast SPORE (the Bay Area Specialized Program of Research Excellence in Breast Cancer). Dr. Rugo teaches medical students, physicians and regularly lectures locally, nationally and internationally on subjects relating to the treatment of breast cancer. At UCSF, Dr. Rugo runs the Breast Forum, an open bimonthly evening educational session for breast cancer patients, families and friends from throughout the bay area.

Dr. Rugo graduated from the University of Pennsylvania School of Medicine in 1983. She completed a residency in internal medicine and primary care followed by a fellowship in hematology and oncology at the University of California San Francisco. She was a post-doctoral fellow in immunology participating in laboratory research at Stanford University from 1988-1990. In 1990, Dr. Rugo joined the faculty at UCSF in the Division of Hematology and Oncology. Dr. Rugo has been recognized for her excellence in both patient care and in teaching of both medical students and training physicians. She has received several awards including the Bank of America Gianini Foundation Award and a UCSF Clinical Cancer Center Investigator Research Program intra-mural award. In 2006, she was honored for her work in Breast Cancer Research by the Friends of the Breast Care Center.

Dr. Shaheenah Dawood, Dubai

M. B. B.Ch

Dr. Shaheenah Dawood is the Head of Medical Oncology and the Head of the Breast Cancer Program at Dubai Hospital in the United Arab Emirates. Dr. Dawood completed her M.B.B.Ch at Dubai Medical College in 1998 and a Master of Public Health degree at the Harvard School of Public Health, Boston, USA in 2008. Her postgraduate medical training programs include a Fellowship at McGill University in Canada in 2006, and the Susan Komen Breast Cancer Fellowship at the University of Texas M.D. Anderson Cancer Center in 2007.

Dr. Dawood is a member of various professional organizations, including the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), the Canadian Association of Medical Oncologists, the Emirates Medical Association, and the Inflammatory Breast Cancer Research Group. She is also the co-director of the Middle East Research Network.

Dr. Dawood has been a primary author or collaborator on over 50 peer-reviewed publications in national and international journals. In addition, she has collaborated with other authors to write a number of book chapters. Dr. Dawood has also been involved as a journal reviewer and as an editorial consultant for many cancer-related journals.

Research Interests: Dr. Dawood’s researcher interests encompass Triple Negative Breast Cancer, Inflammatory Breast Cancer, Metastases, as well as life-style issues and survival outcome of cancer patients.

We will get back soon......!